The Food and Drug Administration (FDA) has approved a drug that comes with a $2.15 million price tag, the most expensive drug ever, Medical Express reports.
Swiss drugmaker Novartis has gained approval to sell Zolgensma (Onasemnogene abeparvovec, or AVXS-101) through its U.S. subsidiary AveXis. The drug treats spinal muscular atrophy, an extremely rare genetic condition that manifests at birth. Infants with the disease have no muscle control, and eventually are rendered unable to move, breathe, or swallow. Almost all die within their first two years of life. The disease affects about 400 children born each year in the United States.
The drug will be administered to children under two years of age who have been confirmed via a genetic test to have the disease. The medicine will be introduced via an infusion that should take about an hour.
0 comments :
Post a Comment